tirzepatide for dogs Peptide of the Week: Tirzepatide, a Game Changer Type 2 Diabetes and Obesity Management Pet Safety Alert: Rising GLP-1

Semaglutide activates specific brain receptors that control appetite and blood sugar, leading to sustained weight loss

Today, it is widely recognised for its ability to promote relaxation and reduce those pesky stress levels.

BMJ-MAGIC Group publishes recommendations for using SGLT-2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes.

A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight loss was associated with a marked drop in drinking over 10 months, with his AUDIT score falling from 27 to 7 and alcohol use dropping from about 15 drinks per week to half a beer per month

We just published data showing that members on GLP-1 therapy who received concurrent nutrition support saved $168 PMPM more than matched members on GLP-1s alone

Austin-based medical team.